Crestline Management »

Syndax Pharmaceuticals shares owned by Crestline Management

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Crestline Management from 13F filings

Historical chart of Crestline Management investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Crestline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Crestline Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2M 101k 21.61
2023-09-30 $2.0M 135k 14.52
2023-06-30 $2.4M 113k 20.93
2023-03-31 $2.0M 95k 21.12
2022-12-31 $1.6M 64k 25.45
2022-09-30 $1.5M 64k 24.03
2022-06-30 $1.2M 61k 19.24
2022-03-31 $1.1M 64k 17.38
2018-06-30 $246k 35k 7.02
2018-03-31 $522k 37k 14.22
2017-12-31 $728k 83k 8.76
2017-09-30 $626k 54k 11.69
2017-06-30 $773k 55k 13.96